Loading…

Microglia Induce Motor Neuron Death via the Classical NF-[kappa]B Pathway in Amyotrophic Lateral Sclerosis

Neuroinflammation is one of the most striking hallmarks of amyotrophic lateral sclerosis (ALS). Nuclear factor-kappa B (NF-κB), a master regulator of inflammation, is upregulated in spinal cords of ALS patients and SOD1-G93A mice. In this study, we show that selective NF-κB inhibition in ALS astrocy...

Full description

Saved in:
Bibliographic Details
Published in:Neuron (Cambridge, Mass.) Mass.), 2014-03, Vol.81 (5), p.1009
Main Authors: Frakes, Ashley E, Ferraiuolo, Laura, Haidet-Phillips, Amanda M, Schmelzer, Leah, Braun, Lyndsey, Miranda, Carlos J, Ladner, Katherine J, Bevan, Adam K, Foust, Kevin D, Godbout, Jonathan P, Popovich, Phillip G, Guttridge, Denis C, Kaspar, Brian K
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Neuroinflammation is one of the most striking hallmarks of amyotrophic lateral sclerosis (ALS). Nuclear factor-kappa B (NF-κB), a master regulator of inflammation, is upregulated in spinal cords of ALS patients and SOD1-G93A mice. In this study, we show that selective NF-κB inhibition in ALS astrocytes is not sufficient to rescue motor neuron (MN) death. However, the localization of NF-κB activity and subsequent deletion of NF-κB signaling in microglia rescued MNs from microglial-mediated death in vitro and extended survival in ALS mice by impairing proinflammatory microglial activation. Conversely, constitutive activation of NF-κB selectively in wild-type microglia induced gliosis and MN death in vitro and in vivo. Taken together, these data provide a mechanism by which microglia induce MN death in ALS and suggest a novel therapeutic target that can be modulated to slow the progression of ALS and possibly other neurodegenerative diseases by which microglial activation plays a role.
ISSN:0896-6273
1097-4199
DOI:10.1016/j.neuron.2014.01.013